The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Cathepsin L

Cathepsin L

Cathepsin L is a lysosomal cysteine proteinase that plays a key role in protein degradation and turnover.
It is involved in a variety of physiological processes, including antigen presentation, bone remodeling, and cancer metastasis.
Cathepsin L has been extensively studied as a potential therapeutic target for a range of diseases, making it an important subject for biomedical research.
PubCompare.ai is an AI-driven platform that can enhance the reproducibility and accuracy of Cathepsin L studies by helping researchers easily locate relevant protocols from literature, preprints, and patents, while providing AI-driven comparisons to idnetify the best protocols and products for their research.
This tool can help streamline Cathepsin L studies and accelerate scientific discovery in this important field.

Most cited protocols related to «Cathepsin L»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
beta-N-Acetylglucosaminidase Buffers carbobenzoxyphenylalanine Cathepsin L Cathepsins Cells Cytosol Digitonin Edetic Acid Egtazic Acid enzyme activity HEPES Magnesium Chloride oxytocin, 1-desamino-(O-Et-Tyr)(2)- Pefabloc phenylalanylarginine Promega Sodium Acetate Sodium Citrate Sucrose Titrimetry
ALLN (Ac-Leu-Leu-Nle-al), Epoxomicin (Epox), CA-074Me, cathepsin G inhibitor I, cathepsin L inhibitor II, synthetic cell-permeable calpastatin peptide, and scrambled peptide were purchased from Millipore. MDL28170, E-64D, cathepsin L inhibitor III, and proteasome substrate Suc-LLVY-AMC were purchased from Enzo life sciences. MG132, cycloheximide, pepstatin A, and L-685,458 were purchased from Sigma-Aldrich. MK-0822 (Odanacatib) was purchased from ChemieTek. The anti-Myc antibody (9B11) was obtained from Cell Signaling. The anti-APP C-terminal antibody C1/6.1 and anti-β-amyloid (1–16) antibody 6E10 were purchased from Covance. The G12A antibody for APP (rabbit polyclonal, clone C7 targeting amino acid residues 732–751 of APP751, custom-manufactured by Thermo Fisher Scientific Inc.) has been previously described.17 (link) The anti-Talin antibody (TA205) and protease inhibitor cocktail were purchased from Millipore. The mouse anti-β-actin antibody was purchased from Sigma-Aldrich. The anti-BACE1 antibody (PA1–757) was purchased from Thermo Scientific. The APP695-Myc construct in pcDNA3.1 was a generous gift from B. T. Hyman at Harvard University.
Publication 2015
acetylleucyl-leucyl-norleucinal Actins aloxistatin Amino Acids Amyloid anti-c antibody Antibodies, Anti-Idiotypic BACE1 protein, human CA-074Me calpastatin Cathepsin L Clone Cells Cycloheximide epoxomicin Immunoglobulins L 685458 MDL 28170 MG 132 MK-0822 Multicatalytic Endopeptidase Complex Mus odanacatib pepstatin Peptides Permeability Protease Inhibitors Rabbits Talin Z-Phe-Gly-NHO-Bz
Samples from amniotic fluid (1 mL) and fragments of approximately 1 cm3 of each placenta, stillborn and aborted fetus organs were collected, and preserved in 99% ethanol. The DNA preparations were subjected to a highly sensitive PCR assay specific for T. vivax standardized by Cortez et al. [22 (link)]. This PCR method targets repeated gene sequences that encode cysteine proteases (Cathepsin L) and was carried out using the oligonucleotides Tvi2 (forward: 5’ GCC ATC GCC AAG TAC CTC GCC GA 3’) and DTO156 (reverse: 5’ TTAGAATTCCCAGGAGTTCTTGATGATCCAGTA 3’) as primers. The diagnosis was confirmed by PCR and amplifying a DNA fragment of about 177 base pairs (bp) that is also observed in the DNA of T. vivax (from Catolé do Rocha, Paraiba, Northeastern Brazil), which was used as a positive control. DNA samples from amniotic fluid, blood, and tissues of the non-infected ewes (G3 and G4) were used as negative controls.
Full text: Click here
Publication 2013
Amniotic Fluid Biological Assay BLOOD Cathepsin L Cysteine Proteases Diagnosis Ethanol Fetuses, Aborted Genes Oligonucleotide Primers Oligonucleotides Placenta Repetitive Region Tissues
Mice were kindly provided as follows: NLRP3−/− and ASC−/− (Millenium Pharmaceuticals); Caspase-1−/− (R. Flavell, Yale University, New Haven, CT). Cathepsin B−/− (T. Reinheckel, Albert-Ludwigs-University, Freiburg, Germany), Cathepsin L−/− (H. Ploegh, Whitehead Institute, Cambridge, MA), IL-1α−/− IL-1β−/−, IL-1α−/−β−/− (Yoichiro Iwakura, The Institute of Medical Sciences, The University of Tokyo, Tokyo, Japan). B6-129 (mixed background), C57BL/6, IL-1R−/−, ApoE−/− and LDLR−/− mice were purchased from The Jackson Laboratories. Animal experiments were approved by the UMass and Massachusetts General Hospital Animal Care and Use Committees.
Publication 2010
Animals ApoE protein, human Caspase 1 Cathepsin L CTSB protein, human Interleukin-1 beta LDLR protein, human Mus Pharmaceutical Preparations
Recombinant F. hepatica procathepsin L1, L2 and L3 (FhCL1, FhCL2 and FhCL3) were produced in yeast as previously described [22] (link), [23] (link). Briefly, P. pastoris (for FhCL1 and FhCL2 expression) and P. angusta (for FhCL3 expression) yeast transformants were cultured in 500 ml BMGY broth, buffered to pH 8.0, in 5 L baffled flasks at 30°C until an OD600 of 2–6 was reached. Cells were harvested by centrifugation at 2000× g for 5 min and protein expression induced by resuspending in 100 ml BMMY broth, buffered at pH 6.0 containing 1% methanol. Recombinant proteins were affinity purified from yeast using Ni-NTA-agarose. Recombinant propeptidases were dialysed against phosphate buffered saline (PBS) and stored at −20°C. The 37 kDa cathepsin L zymogens were autocatalytically activated and processed to 24.5 kDa mature enzymes by incubation for 2 h at 37°C in 0.1 M sodium citrate buffer (pH 5.0) containing 2 mM DTT and 2.5 mM EDTA. The mixture was then dialysed against PBS, pH 7.3. The proportion of functionally active recombinant protein in these preparations was determined by titration against E-64.
Full text: Click here
Publication 2011
Cathepsin L Cells Centrifugation Edetic Acid Enzyme Precursors Enzymes FH3 Hepatica Hyperlipoproteinemia Type IIa Hyperlipoproteinemia Type IIb Methanol Phosphates Proteins Recombinant Proteins Saccharomyces cerevisiae Saline Solution Sepharose Sodium Citrate Titrimetry

Most recents protocols related to «Cathepsin L»

Wild-type human EBC1 (EBC1/WT), NCI-H441, NCI-H1993, SNU-5, T47D, and HeLa cells were obtained from the ATCC, cultured in the manufacturer's recommended media up to passage 15–20, authenticated by short tandem repeat profiling and Mycoplasma tested in the last 1–3 years (IDEXX BioResearch).
EBC1/WT cells were engineered to stably express Cas9 nuclease by lentiviral infection (pLentiCas9-Blast) and selection with blasticidin (EBC1/Cas9). To generate EBC1/Cas9 cells stably knocked out for Rab11a and Rab5c, cells were plated in tissue culture-treated 12-well plates (Corning) at 200,000 cells/well. On day 2, cells were preincubated with 5 μg/mL polybrene for 30 minutes at 37°C and infected with lentiviruses (pLenti-H1-gRNA, Gentarget) for 24 hours at a multiplicity of infection of 4. Puromycin selection was initiated 2 days after infection. The lentiviruses encoded guide RNA against Rab11a (GCACAGATATGGGACACAGC, GAGTGATCTACGTCATCTCA or CATGTCTCCAAGCAACAATG), Rab5c (CAAGATCTGTCAATTTAAGC, TCCTCAGGATACATTTGCAC, TCCAGGCCGAAACCGAGGTG) or control (GTCTCCACGCGCAGTACATT). Knockout efficiency was determined by Western blot (WB) analysis and cells were used for experiments up to six passages after the beginning of selection or until an increase in the target expression was observed.
To generate EBC1 cells expressing endosomal markers, EBC1/WT cells were infected with the same protocol as above. The lentiviruses (Gentarget) encoded cDNA sequences of Rab5c (GenBank: U18420.1), Rab11a (GenBank: AF000231.1), or Rab7a (GenBank: AF050175.1), terminally fused to the N-terminus of GFP under the control of suCMV promoter. Puromycin selection was initiated 2 days after infection and cells were sorted for GFP-positive expression. To transciently knock down cathepsin-L in EBC1/WT, EBC1/Rab11a-GFP or EBC1/Rab5c-GFP, 10,000 cells were plated in collagen-coated, 96-well optical plates (Greiner #655956). Transfections were performed the next day with 5 pmol siRNA (Dharmacon #J-005841-11-0005; Invitrogen #4390824) and 0.25 μL Lipofectamine RNAiMax (Invitrogen) in a final volume of 100 μL Optimem (Invitrogen) per well. METxMET-VC-biosensor assays were performed 3 days posttransfection as described below and samples were lysed to determine cathepsin-L knockdown efficiency with WB analysis.
Publication 2023
Biological Assay Biosensors Cathepsin L Cells Collagen Culture Media DNA, Complementary Endosomes HeLa Cells Homo sapiens Infection Lentivirus Lipofectamine Mycoplasma Polybrene Puromycin RNA, Small Interfering Short Tandem Repeat Tissues Transfection Western Blot
A slightly modified protocol
from the commercially available assay (BPS Bioscience) was used. Dithiothreitol
was substituted with tris(2-carboxyethyl)phosphine (TCEP), the latter
of which was found not to alter the activity of the enzyme in the
assay. The cathepsin L enzyme was thawed on ice and activated by dilution
to 10.0 ng/μL with assay buffer. The enzyme solution was further
diluted with assay buffer to 0.02 ng/μL. Twenty microliters
of the enzyme solution was mixed with 5 μL of increasing concentrations
of the complex [2% (v/v) DMSO] diluted in assay buffer in the dark.
The substrate (Z-Leu-Arg-AMC) was diluted to 10 μM, and 25 μL
was added to the enzyme mixture. This yields a mixture containing
10 mM Tris-HCl, 0.05% glycerol, 300 μM TCEP, and 10 μM
cathepsin L substrate. The mixture was incubated for 60 min at 37
°C with slow shaking. The generated fluorescence signal (λex = 360 nm; λem = 460 nm) was recorded with
a Synergy H4 (BioTek) microplate reader. As a positive control, the
known inhibitor E-64 (IC50 = 33 ± 9 nM) was used.
Full text: Click here
Publication 2023
arginine 4-methyl-7-coumarylamide Biological Assay Buffers Cathepsin L enzyme activity Enzymes Fluorescence Glycerin phosphine Sulfoxide, Dimethyl tris(2-carboxyethyl)phosphine Tromethamine
The 3CLpro (SARS-CoV-2) assay kit (BPS Bioscience, San Diego CA, cat. no. 78042-2) is designed to measure 3CLpro activity and identify inhibitors of this enzyme, while human cathepsin L inhibitor screening kit (abcam, cat. Cambridge, UK, No. ab197012) and human calpain activity assay kit (AnaSpec. Inc. Fremont CA, cat. No. AS-72149) are designed to measure human cysteine protease activity and identify inhibitors of these enzymes. These assays were performed in a 96-well plate using a fluorogenic substrate. Briefly, a solution of each enzyme was prepared according to the manufacturer’s protocol in assay buffer. Separately, solutions of test compounds necessary to generate a seven-point dose response curve were prepared in half-log serial dilution. Test compounds were added to the plate, and the mixture was preincubated for 30 min at room temperature. A blank well (no enzyme) was included to assess the background signal, while the known inhibitors GC376, FF-FMK and B27-WT were used as positive controls for SARS-CoV-2 Mpro/3CLpro, cathepsin L, and calpain, respectively. The plates of SARS-CoV-2 Mpro, cathepsin L, and calpain were incubated with each fluorogenic substrate for 4, 0.3, and 1 h, respectively, at room temperature. Then fluorescence intensity was measured in a Cytation 5 cell imaging multi-mode reader (BioTek, Winooski, VT, USA)(excitation/emission: 360/460 nm, excitation/emission: 400/505 nm, and excitation/emission: 490/520 nm), respectively. End point fluorescence intensities were measured, and the blank value were subtracted from all values.
Full text: Click here
Publication 2023
Biological Assay Buffers Calpain Cathepsin L Cells Cysteine Proteases Enzyme Inhibitors Enzymes Fluorescence Fluorogenic Substrate GC376 Homo sapiens inhibitors SARS-CoV-2 Technique, Dilution
Lysosomal abundance and acidity were analyzed as previously described (27 (link)) using LTRLysoTracker Red DND-99 (Life Technologies, L7528) and LysoSensor Green DND-189; (Life Technologies, L7535) and flow cytometric measurement. Staining and analyses were performed according to the manufacturer’s instructions and modified protocol. LysoTracker probes detect lysosomal mass as they accumulate in lysosomes and exhibit pH-independent fluorescence. LysoSensor reagents detect lysosomal acidity as their fluorescence is largely pH-dependent and increase upon acidification. Briefly, around 5x104 cells per well seeded in 96-well plate were centrifuged at 865g for 10 min. at 4°C. Then cells were washed once with PBS and suspended in 100μL of PBS containing LTR (66nM) or LSG (1μM) and incubated at 37°C in a 5% CO2 incubator for 30 min. After one more washing step cells were suspended in 50mL of PBS put on ice and analyzed on a flow cytometer. Analysis was performed using LSR II (Becton Dickinson, Biosciences) and the data of cell counts plotted as GFP fluorescence intensity for LSG to PE-Texas Red for LTR. Cathepsin B (ImmunoChemistry Technologies, 938) and L (ImmunoChemistry Technologies, 942) enzymatic activity were analyzed by flow cytometric measurement using Magic Red Cathepsin L and B assay kits (ImmunoChemistry Technologies) according to manufacturer’s instructions and as previously described (27 (link)). Analysis was performed using LSR II (Becton Dickinson, Biosciences) and the data of cell counts plotted as PE-Texas Red fluorescence intensity. Autophagosomes are an intermediate structure of a dynamic degradation process and their absolute amount at a particular time point is a function of their generation and degradation upon autolysosomal fusion (31 (link)). Measurement of autophagic flux gives an informative picture about the overall autolysosomal digestive activity and the successful execution of autolysosomal fusion (31 (link)). Transgenic expression of a tandem mCherry-GFP -tagged LC3 represents a very sensitive fluorescence assay designed to monitor autophagic flux using confocal microscopy as well as flow cytometry (31 (link), 32 (link)). mCherry-GFP-LC3 was visualized using confocal fluorescence microscopy according to recently updated guidelines (31 (link)). the mCherry-GFP-LC3 cytoplasmic pool is visualized as a homogeneously dispersed signal and autophagosomes with dual mCherry-GFP-LC3-II color as yellow punctae formation. Autolysosomal fusion leads to the quenching of the GFP signal and therefore the resulting autolysosome is detected as single color red punctae. Therefore using mCherry-GFP-LC3 tandem expressing cells autophagy induction is detected as an increase in both yellow and red punctae as late autophagy inhibition as an increase in only yellow punctae (31 (link)). In each treatment condition fluorescence images were taken from numerous cells from several randomly chosen fields with Leica DM IRB microscope equipped with a TCS SP2 AOBS scan head (Leica, Germany). Alternatively, autophagic flux (turnover) was analyzed using Cyto-ID®Autophagy Detection Kit (Enzo Life Sciences, ENZ-51031-K200) by following the manufacturer’s instructions and as previously described (22 (link), 24 (link), 25 (link)). Autophagic flux (ΔMFI Cyto-ID) is measured through the accumulation of autophagic compartments (total cellular Cyto-ID signal) after blockage of autolysosome degradation through incubation with lysosomotropic compound NH4Cl, which elevates/neutralizes the lysosomal pH. ΔMFI Cyto-ID = MFI Cyto-ID (NH4Cl) - MFI Cyto-ID (-NH4Cl).
Full text: Click here
Publication 2023
Animals, Transgenic Autolysosome Autophagosome Autophagy Biological Assay Cathepsin B Cathepsin L Cells Cytoplasm Digestive System enzyme activity Flow Cytometry Fluorescence Head Heartburn LysoSensor Green DND-189 Lysosomes LysoTracker Microscopy Microscopy, Confocal Microscopy, Fluorescence Psychological Inhibition Radionuclide Imaging Red DND-99 Signal Transduction
Treated cells were lysed (30 mM Tris-HCl, pH 7.5, at 21°C, 120 mM NaCl, 10% glycerol, 1% Triton X-100, and Complete protease inhibitor cocktail [Roche, Germany]) for 30 min on ice and 5 micrograms of total cellular protein were separated by SDS-PAGE on 4-12% gradient gels (Invitrogen, Karlsruhe, Germany).After blocking step for 2 hours at RT, the membranes were incubated with the following primary antibodies: cathepsin L (AF952), cathepsin B (AF953) from R&D systems, anti-LC3 (L8918), actin Ab (A2103) from Sigma. Bands were visualized with an ECL detection kit (Amersham, Freiburg, Germany). For density analysis of western blot bands with ImageJ, a protocol was used as described elsewhere (30 (link)).
Full text: Click here
Publication 2023
Actins Antibodies Cardiac Arrest Cathepsin L Cells CTSB protein, human Gels Glycerin Protease Inhibitors Proteins SDS-PAGE Sodium Chloride Tissue, Membrane Triton X-100 Tromethamine Western Blot

Top products related to «Cathepsin L»

Sourced in United States
Cathepsin L is a proteolytic enzyme that belongs to the cysteine protease family. It plays a crucial role in protein degradation and processing within cells. Cathepsin L is involved in various biological processes, including antigen presentation, bone remodeling, and tissue remodeling. This lab equipment product can be used to study the function and regulation of Cathepsin L in research settings.
Sourced in United Kingdom, United States
The Cathepsin L Activity Assay Kit is a colorimetric assay designed to measure the activity of the lysosomal cysteine protease Cathepsin L in biological samples. The kit uses a specific Cathepsin L substrate that, upon cleavage, generates a colored product which can be quantified using a spectrophotometer.
Sourced in United States
CA-074 Me is a laboratory reagent produced by Merck Group. It is a cathepsin B inhibitor with a core function of inhibiting the enzymatic activity of cathepsin B. No further details on intended use are provided.
Sourced in United States
Cathepsin L is a cysteine protease enzyme that is involved in various cellular processes, including protein turnover, antigen presentation, and cell signaling. It plays a role in the degradation of extracellular matrix proteins and is associated with various physiological and pathological conditions.
Sourced in United States, United Kingdom, China, Germany, Japan, Canada, Morocco, France, Netherlands, Ireland, Israel, Australia, Sweden, Macao, Switzerland
GAPDH is a protein that functions as an enzyme involved in the glycolysis process, catalyzing the conversion of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate. It is a common reference or housekeeping protein used in various assays and analyses.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in Japan, United States
Cathepsin B is a lysosomal cysteine protease that plays a role in various physiological and pathological processes. It is involved in protein degradation and processing, and has been implicated in conditions such as cancer, inflammation, and neurodegeneration. Cathepsin B is commonly used as a research tool to study these processes.
Sourced in United States, United Kingdom, Germany, Japan, France, China, Spain
LysoTracker Red DND-99 is a fluorescent dye that selectively stains acidic organelles, such as lysosomes, in live cells. It can be used to visualize and monitor the distribution and activity of lysosomes within the cellular environment.
Sourced in United States
Cathepsin S is a proteolytic enzyme that belongs to the papain family of cysteine proteases. It is primarily involved in the degradation of proteins within lysosomes. Cathepsin S plays a role in the processing of antigens for presentation on major histocompatibility complex class II molecules.
Sourced in United States, Germany, Japan, China, Sao Tome and Principe, France, Italy, India, Canada, United Kingdom, Belgium, Poland, Austria, Spain
Pepstatin A is a peptide inhibitor that specifically targets aspartic proteases. It is commonly used in biochemical research applications to inhibit the activity of proteases such as pepsin, renin, and cathepsin D.

More about "Cathepsin L"

Cathepsin L is a crucial lysosomal cysteine protease involved in various physiological processes, including protein degradation, antigen presentation, bone remodeling, and cancer metastasis.
This important enzyme has been extensively studied as a potential therapeutic target for a range of diseases, making it a subject of significant biomedical research.
PubCompare.ai is an AI-driven platform that can enhance the reproducibility and accuracy of Cathepsin L studies.
This tool helps researchers easily locate relevant protocols from literature, preprints, and patents, while providing AI-driven comparisons to identify the best protocols and products for their research.
By streamlining Cathepsin L studies, PubCompare.ai can accelerate scientific discovery in this important field.
Cathepsin L Activity Assay Kits are commonly used to measure the activity of this enzyme, which is involved in processes like antigen processing, bone remodeling, and tumor invasion.
CA-074 Me is a selective inhibitor of Cathepsin B, another lysosomal protease, and can be used in conjunction with Cathepsin L studies.
GAPDH, or Glyceraldehyde 3-phosphate dehydrogenase, is a commonly used housekeeping gene and protein that can serve as a loading control in experiments involving Cathepsin L.
DMSO (Dimethyl sulfoxide) is a solvent often used to dissolve compounds, including inhibitors like CA-074 Me, in Cathepsin L research.
In addition to Cathepsin L, other cathepsins like Cathepsin B and Cathepsin S play important roles in various physiological and pathological processes.
Pepstatin A is a general protease inhibitor that can be used to study the role of cathepsins in different contexts.
LysoTracker Red DND-99 is a fluorescent dye that can be used to visualize and study lysosomal structures, which are the cellular compartments where Cathepsin L is primarily located and active.